e-learning
resources
Vienna 2003
Sunday 28.09.2003
Interstitial lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognosis of pulmonary Langerhans' cell granulomatosis
Z. Z. Pavlovic-Popovic, B. D. Djuric, O. K. Maksimovic, S. M. Kasikovic-Lecic (Sremska Kamenica, Yugoslavia)
Source:
Annual Congress 2003 - Interstitial lung diseases
Session:
Interstitial lung diseases
Session type:
Thematic Poster Session
Number:
394
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Z. Pavlovic-Popovic, B. D. Djuric, O. K. Maksimovic, S. M. Kasikovic-Lecic (Sremska Kamenica, Yugoslavia). Prognosis of pulmonary Langerhans' cell granulomatosis. Eur Respir J 2003; 22: Suppl. 45, 394
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004
Two different clinical forms of pulmonary langerhans cell granulomatosis
Source: Eur Respir J 2002; 20: Suppl. 38, 471s
Year: 2002
Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
Pulmonary Langerhans' cell histiocytosis
Source: Eur Respir Mon; 2009: 46: 155–175
Year: 2009
Bronchocentric granulomatosis and pulmonary tumourlet mimicking lung cancer
Source: Annual Congress 2008 - Various thoracic tumours and interesting cases
Year: 2008
Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020
Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012
Pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008
Pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006
Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016
Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma
Source: Eur Respir Rev 2009; 19: 86-88
Year: 2010
Pulmonary hypertension in orphan lung diseases
Source: Eur Respir Mon 2011; 54: 317-331
Year: 2011
Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018
How I manage pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017
Year: 2017
Lung transplantation for pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Langerhans cell histiocytosis: is it an ILD?
Source: Virtual Congress 2021 – Interstitial lung diseases
Year: 2021
Spontaneous resolutive pulmonary necrotizing granulomatosis
Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases
Year: 2020
Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis
Source: Eur Respir Mon 2012; 57: 161-165
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept